Global Recombinant Proteins Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 19-Oct-2021
No. of pages: 104

The Recombinant Proteins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Recombinant Proteins size is estimated to be USD 923.1 million in 2026 from USD 684.8 million in 2020, with a change XX% between 2020 and 2021. The global Recombinant Proteins market size is expected to grow at a CAGR of 7.8% for the next five years.

Market segmentation

Recombinant Proteins market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Hormones

- Growth Factors

- Cytokines

- Plasma Protein Factor

- Recombinant Metabolic Enzymes

- Immune Checkpoint Regulators

- Others

Market segment by Application, can be divided into

- Biopharmaceutical Companies

- Academic and Research Institutes

- Contract Research Organizations

Market segment by players, this report covers

- Abcam PLC

- R&D Systems

- Miltenyi Biotec

- Thermo Fisher Scientific

- Sigma Aldrich Company

- GE Healthcare

- Lonza

- Merck KGaA

- ProSpec Tany TechnoGene

- Eurogentec (Kaneka Corporation)

- PeproTech

- BPS Bioscience

- Reprocell

- GenScript Biotech Corporation

- Abnova Corporation

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Recombinant Proteins product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Recombinant Proteins, with revenue, gross margin and global market share of Recombinant Proteins from 2019 to 2021.

Chapter 3, the Recombinant Proteins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Recombinant Proteins market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Recombinant Proteins research findings and conclusion, appendix and data source.

Global Recombinant Proteins Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Recombinant Proteins
1.2 Classification of Recombinant Proteins by Type
1.2.1 Overview: Global Recombinant Proteins Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Recombinant Proteins Revenue Market Share by Type in 2020
1.2.3 Hormones
1.2.4 Growth Factors
1.2.5 Cytokines
1.2.6 Plasma Protein Factor
1.2.7 Recombinant Metabolic Enzymes
1.2.8 Immune Checkpoint Regulators
1.2.9 Others
1.3 Global Recombinant Proteins Market by Application
1.3.1 Overview: Global Recombinant Proteins Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Global Recombinant Proteins Market Size & Forecast
1.5 Global Recombinant Proteins Market Size and Forecast by Region
1.5.1 Global Recombinant Proteins Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Recombinant Proteins Market Size by Region, (2016-2021)
1.5.3 North America Recombinant Proteins Market Size and Prospect (2016-2026)
1.5.4 Europe Recombinant Proteins Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Recombinant Proteins Market Size and Prospect (2016-2026)
1.5.6 South America Recombinant Proteins Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Recombinant Proteins Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Proteins Market Drivers
1.6.2 Recombinant Proteins Market Restraints
1.6.3 Recombinant Proteins Trends Analysis
2 Company Profiles
2.1 Abcam PLC
2.1.1 Abcam PLC Details
2.1.2 Abcam PLC Major Business
2.1.3 Abcam PLC Recombinant Proteins Product and Solutions
2.1.4 Abcam PLC Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abcam PLC Recent Developments and Future Plans
2.2 R&D Systems
2.2.1 R&D Systems Details
2.2.2 R&D Systems Major Business
2.2.3 R&D Systems Recombinant Proteins Product and Solutions
2.2.4 R&D Systems Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 R&D Systems Recent Developments and Future Plans
2.3 Miltenyi Biotec
2.3.1 Miltenyi Biotec Details
2.3.2 Miltenyi Biotec Major Business
2.3.3 Miltenyi Biotec Recombinant Proteins Product and Solutions
2.3.4 Miltenyi Biotec Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Miltenyi Biotec Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Recombinant Proteins Product and Solutions
2.4.4 Thermo Fisher Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Sigma Aldrich Company
2.5.1 Sigma Aldrich Company Details
2.5.2 Sigma Aldrich Company Major Business
2.5.3 Sigma Aldrich Company Recombinant Proteins Product and Solutions
2.5.4 Sigma Aldrich Company Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sigma Aldrich Company Recent Developments and Future Plans
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Recombinant Proteins Product and Solutions
2.6.4 GE Healthcare Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GE Healthcare Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Recombinant Proteins Product and Solutions
2.7.4 Lonza Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Lonza Recent Developments and Future Plans
2.8 Merck KGaA
2.8.1 Merck KGaA Details
2.8.2 Merck KGaA Major Business
2.8.3 Merck KGaA Recombinant Proteins Product and Solutions
2.8.4 Merck KGaA Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merck KGaA Recent Developments and Future Plans
2.9 ProSpec Tany TechnoGene
2.9.1 ProSpec Tany TechnoGene Details
2.9.2 ProSpec Tany TechnoGene Major Business
2.9.3 ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions
2.9.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 ProSpec Tany TechnoGene Recent Developments and Future Plans
2.10 Eurogentec (Kaneka Corporation)
2.10.1 Eurogentec (Kaneka Corporation) Details
2.10.2 Eurogentec (Kaneka Corporation) Major Business
2.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Product and Solutions
2.10.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Eurogentec (Kaneka Corporation) Recent Developments and Future Plans
2.11 PeproTech
2.11.1 PeproTech Details
2.11.2 PeproTech Major Business
2.11.3 PeproTech Recombinant Proteins Product and Solutions
2.11.4 PeproTech Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 PeproTech Recent Developments and Future Plans
2.12 BPS Bioscience
2.12.1 BPS Bioscience Details
2.12.2 BPS Bioscience Major Business
2.12.3 BPS Bioscience Recombinant Proteins Product and Solutions
2.12.4 BPS Bioscience Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 BPS Bioscience Recent Developments and Future Plans
2.13 Reprocell
2.13.1 Reprocell Details
2.13.2 Reprocell Major Business
2.13.3 Reprocell Recombinant Proteins Product and Solutions
2.13.4 Reprocell Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Reprocell Recent Developments and Future Plans
2.14 GenScript Biotech Corporation
2.14.1 GenScript Biotech Corporation Details
2.14.2 GenScript Biotech Corporation Major Business
2.14.3 GenScript Biotech Corporation Recombinant Proteins Product and Solutions
2.14.4 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 GenScript Biotech Corporation Recent Developments and Future Plans
2.15 Abnova Corporation
2.15.1 Abnova Corporation Details
2.15.2 Abnova Corporation Major Business
2.15.3 Abnova Corporation Recombinant Proteins Product and Solutions
2.15.4 Abnova Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Abnova Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Recombinant Proteins Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Recombinant Proteins Players Market Share
3.2.2 Top 10 Recombinant Proteins Players Market Share
3.2.3 Market Competition Trend
3.3 Recombinant Proteins Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Recombinant Proteins Revenue and Market Share by Type (2016-2021)
4.2 Global Recombinant Proteins Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Recombinant Proteins Revenue Market Share by Application (2016-2021)
5.2 Recombinant Proteins Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Recombinant Proteins Revenue by Type (2016-2026)
6.2 North America Recombinant Proteins Revenue by Application (2016-2026)
6.3 North America Recombinant Proteins Market Size by Country
6.3.1 North America Recombinant Proteins Revenue by Country (2016-2026)
6.3.2 United States Recombinant Proteins Market Size and Forecast (2016-2026)
6.3.3 Canada Recombinant Proteins Market Size and Forecast (2016-2026)
6.3.4 Mexico Recombinant Proteins Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Recombinant Proteins Revenue by Type (2016-2026)
7.2 Europe Recombinant Proteins Revenue by Application (2016-2026)
7.3 Europe Recombinant Proteins Market Size by Country
7.3.1 Europe Recombinant Proteins Revenue by Country (2016-2026)
7.3.2 Germany Recombinant Proteins Market Size and Forecast (2016-2026)
7.3.3 France Recombinant Proteins Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Recombinant Proteins Market Size and Forecast (2016-2026)
7.3.5 Russia Recombinant Proteins Market Size and Forecast (2016-2026)
7.3.6 Italy Recombinant Proteins Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Recombinant Proteins Revenue by Type (2016-2026)
8.2 Asia-Pacific Recombinant Proteins Revenue by Application (2016-2026)
8.3 Asia-Pacific Recombinant Proteins Market Size by Region
8.3.1 Asia-Pacific Recombinant Proteins Revenue by Region (2016-2026)
8.3.2 China Recombinant Proteins Market Size and Forecast (2016-2026)
8.3.3 Japan Recombinant Proteins Market Size and Forecast (2016-2026)
8.3.4 South Korea Recombinant Proteins Market Size and Forecast (2016-2026)
8.3.5 India Recombinant Proteins Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Recombinant Proteins Market Size and Forecast (2016-2026)
8.3.7 Australia Recombinant Proteins Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Recombinant Proteins Revenue by Type (2016-2026)
9.2 South America Recombinant Proteins Revenue by Application (2016-2026)
9.3 South America Recombinant Proteins Market Size by Country
9.3.1 South America Recombinant Proteins Revenue by Country (2016-2026)
9.3.2 Brazil Recombinant Proteins Market Size and Forecast (2016-2026)
9.3.3 Argentina Recombinant Proteins Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Recombinant Proteins Revenue by Type (2016-2026)
10.2 Middle East & Africa Recombinant Proteins Revenue by Application (2016-2026)
10.3 Middle East & Africa Recombinant Proteins Market Size by Country
10.3.1 Middle East & Africa Recombinant Proteins Revenue by Country (2016-2026)
10.3.2 Turkey Recombinant Proteins Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Recombinant Proteins Market Size and Forecast (2016-2026)
10.3.4 UAE Recombinant Proteins Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Recombinant Proteins Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Recombinant Proteins Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Recombinant Proteins Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Recombinant Proteins Revenue (USD Million) by Region (2016-2021)
Table 5. Global Recombinant Proteins Revenue Market Share by Region (2021-2026)
Table 6. Abcam PLC Corporate Information, Head Office, and Major Competitors
Table 7. Abcam PLC Major Business
Table 8. Abcam PLC Recombinant Proteins Product and Solutions
Table 9. Abcam PLC Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. R&D Systems Corporate Information, Head Office, and Major Competitors
Table 11. R&D Systems Major Business
Table 12. R&D Systems Recombinant Proteins Product and Solutions
Table 13. R&D Systems Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Miltenyi Biotec Corporate Information, Head Office, and Major Competitors
Table 15. Miltenyi Biotec Major Business
Table 16. Miltenyi Biotec Recombinant Proteins Product and Solutions
Table 17. Miltenyi Biotec Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Recombinant Proteins Product and Solutions
Table 21. Thermo Fisher Scientific Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sigma Aldrich Company Corporate Information, Head Office, and Major Competitors
Table 23. Sigma Aldrich Company Major Business
Table 24. Sigma Aldrich Company Recombinant Proteins Product and Solutions
Table 25. Sigma Aldrich Company Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 27. GE Healthcare Major Business
Table 28. GE Healthcare Recombinant Proteins Product and Solutions
Table 29. GE Healthcare Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Lonza Corporate Information, Head Office, and Major Competitors
Table 31. Lonza Major Business
Table 32. Lonza Recombinant Proteins Product and Solutions
Table 33. Lonza Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 35. Merck KGaA Major Business
Table 36. Merck KGaA Recombinant Proteins Product and Solutions
Table 37. Merck KGaA Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. ProSpec Tany TechnoGene Corporate Information, Head Office, and Major Competitors
Table 39. ProSpec Tany TechnoGene Major Business
Table 40. ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions
Table 41. ProSpec Tany TechnoGene Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Eurogentec (Kaneka Corporation) Corporate Information, Head Office, and Major Competitors
Table 43. Eurogentec (Kaneka Corporation) Major Business
Table 44. Eurogentec (Kaneka Corporation) Recombinant Proteins Product and Solutions
Table 45. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. PeproTech Corporate Information, Head Office, and Major Competitors
Table 47. PeproTech Major Business
Table 48. PeproTech Recombinant Proteins Product and Solutions
Table 49. PeproTech Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. BPS Bioscience Corporate Information, Head Office, and Major Competitors
Table 51. BPS Bioscience Major Business
Table 52. BPS Bioscience Recombinant Proteins Product and Solutions
Table 53. BPS Bioscience Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Reprocell Corporate Information, Head Office, and Major Competitors
Table 55. Reprocell Major Business
Table 56. Reprocell Recombinant Proteins Product and Solutions
Table 57. Reprocell Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. GenScript Biotech Corporation Corporate Information, Head Office, and Major Competitors
Table 59. GenScript Biotech Corporation Major Business
Table 60. GenScript Biotech Corporation Recombinant Proteins Product and Solutions
Table 61. GenScript Biotech Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Abnova Corporation Corporate Information, Head Office, and Major Competitors
Table 63. Abnova Corporation Major Business
Table 64. Abnova Corporation Recombinant Proteins Product and Solutions
Table 65. Abnova Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Recombinant Proteins Revenue (USD Million) by Players (2019-2021)
Table 67. Global Recombinant Proteins Revenue Share by Players (2019-2021)
Table 68. Breakdown of Recombinant Proteins by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Recombinant Proteins Players Head Office, Products and Services Provided
Table 70. Recombinant Proteins Mergers & Acquisitions in the Past Five Years
Table 71. Recombinant Proteins New Entrants and Expansion Plans
Table 72. Global Recombinant Proteins Revenue (USD Million) by Type (2016-2021)
Table 73. Global Recombinant Proteins Revenue Share by Type (2016-2021)
Table 74. Global Recombinant Proteins Revenue Forecast by Type (2021-2026)
Table 75. Global Recombinant Proteins Revenue by Application (2016-2021)
Table 76. Global Recombinant Proteins Revenue Forecast by Application (2021-2026)
Table 77. North America Recombinant Proteins Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Recombinant Proteins Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Recombinant Proteins Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Recombinant Proteins Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Recombinant Proteins Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Recombinant Proteins Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Recombinant Proteins Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Recombinant Proteins Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Recombinant Proteins Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Recombinant Proteins Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Recombinant Proteins Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Recombinant Proteins Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Recombinant Proteins Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Recombinant Proteins Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Recombinant Proteins Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Recombinant Proteins Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Recombinant Proteins Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Recombinant Proteins Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Recombinant Proteins Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Recombinant Proteins Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Recombinant Proteins Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Recombinant Proteins Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Recombinant Proteins Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Recombinant Proteins Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Recombinant Proteins Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Recombinant Proteins Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Recombinant Proteins Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Recombinant Proteins Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Recombinant Proteins Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Recombinant Proteins Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Recombinant Proteins Picture
Figure 2. Global Recombinant Proteins Revenue Market Share by Type in 2020
Figure 3. Hormones
Figure 4. Growth Factors
Figure 5. Cytokines
Figure 6. Plasma Protein Factor
Figure 7. Recombinant Metabolic Enzymes
Figure 8. Immune Checkpoint Regulators
Figure 9. Others
Figure 10. Recombinant Proteins Revenue Market Share by Application in 2020
Figure 11. Biopharmaceutical Companies Picture
Figure 12. Academic and Research Institutes Picture
Figure 13. Contract Research Organizations Picture
Figure 14. Global Recombinant Proteins Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Recombinant Proteins Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Recombinant Proteins Revenue Market Share by Region (2016-2026)
Figure 17. Global Recombinant Proteins Revenue Market Share by Region in 2020
Figure 18. North America Recombinant Proteins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Recombinant Proteins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Recombinant Proteins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Recombinant Proteins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Recombinant Proteins Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Recombinant Proteins Market Drivers
Figure 24. Recombinant Proteins Market Restraints
Figure 25. Recombinant Proteins Market Trends
Figure 26. Abcam PLC Recent Developments and Future Plans
Figure 27. R&D Systems Recent Developments and Future Plans
Figure 28. Miltenyi Biotec Recent Developments and Future Plans
Figure 29. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 30. Sigma Aldrich Company Recent Developments and Future Plans
Figure 31. GE Healthcare Recent Developments and Future Plans
Figure 32. Lonza Recent Developments and Future Plans
Figure 33. Merck KGaA Recent Developments and Future Plans
Figure 34. ProSpec Tany TechnoGene Recent Developments and Future Plans
Figure 35. Eurogentec (Kaneka Corporation) Recent Developments and Future Plans
Figure 36. PeproTech Recent Developments and Future Plans
Figure 37. BPS Bioscience Recent Developments and Future Plans
Figure 38. Reprocell Recent Developments and Future Plans
Figure 39. GenScript Biotech Corporation Recent Developments and Future Plans
Figure 40. Abnova Corporation Recent Developments and Future Plans
Figure 41. Global Recombinant Proteins Revenue Share by Players in 2020
Figure 42. Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Recombinant Proteins Revenue Market Share in 2020
Figure 44. Global Top 10 Players Recombinant Proteins Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Recombinant Proteins Revenue Share by Type in 2020
Figure 47. Global Recombinant Proteins Market Share Forecast by Type (2021-2026)
Figure 48. Global Recombinant Proteins Revenue Share by Application in 2020
Figure 49. Global Recombinant Proteins Market Share Forecast by Application (2021-2026)
Figure 50. North America Recombinant Proteins Sales Market Share by Type (2016-2026)
Figure 51. North America Recombinant Proteins Sales Market Share by Application (2016-2026)
Figure 52. North America Recombinant Proteins Revenue Market Share by Country (2016-2026)
Figure 53. United States Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Recombinant Proteins Sales Market Share by Type (2016-2026)
Figure 57. Europe Recombinant Proteins Sales Market Share by Application (2016-2026)
Figure 58. Europe Recombinant Proteins Revenue Market Share by Country (2016-2026)
Figure 59. Germany Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Recombinant Proteins Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Recombinant Proteins Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Recombinant Proteins Revenue Market Share by Region (2016-2026)
Figure 67. China Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Recombinant Proteins Sales Market Share by Type (2016-2026)
Figure 74. South America Recombinant Proteins Sales Market Share by Application (2016-2026)
Figure 75. South America Recombinant Proteins Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Recombinant Proteins Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Recombinant Proteins Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Recombinant Proteins Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Recombinant Proteins Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
  • Global Gynecology Partnering 2010-2021: Deal trends, players and financials
    Published: 01-Dec-2021        Price: US 3495 Onwards        Pages: 300
    Global Gynecology Partnering 2010-2021: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Gynecology partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gynecology partnering agreement structure Gynecology partnering contract documents Top Gynecology deals by value Most active......
  • Global Fiberoptic Laryngoscope Market Research Report 2021
    Published: 29-Nov-2021        Price: US 2900 Onwards        Pages: 116
    The global Fiberoptic Laryngoscope market was valued at US$ 64.43 million in 2020 and is expected to reach US$ 105.99 million by the end of 2027, growing at a CAGR of 6.77% during 2021-2027. This report focuses on Fiberoptic Laryngoscope volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fiberoptic Laryngoscope market size by analysing historical data and future prospect. Regionally, this report focuses on sev......
  • Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2021-2027
    Published: 29-Nov-2021        Price: US 3900 Onwards        Pages: 173
    Market Analysis and Insights: Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market This report focuses on global and Japan Beta-lactam and Beta-lactamase Inhibitors market. In 2020, the global Beta-lactam and Beta-lactamase Inhibitors market size was US$ 23715 million and it is expected to reach US$ 31774 million by the end of 2027, with a CAGR of 1.93% during 2021-2027. In Japan the Beta-lactam and Beta-lactamase Inhibitors market size is expected to grow from US$ 202......
  • Global Defibrillators Pads Market Research Report 2021
    Published: 29-Nov-2021        Price: US 2900 Onwards        Pages: 110
    The global Defibrillators Pads market was valued at US$ 167.30 million in 2020 and is expected to reach US$ 277.83 million by the end of 2027, growing at a CAGR of 6.86% during 2021-2027. This report focuses on Defibrillators Pads volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Defibrillators Pads market size by analysing historical data and future prospect. Regionally, this report focuses on several key re......
  • Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026
    Published: 29-Nov-2021        Price: US 4950 Onwards        Pages: 181
    “Increasing blood transfusion and donations is expected to drive the overall growth of the hepatitis testing market.” The global hepatitis testing market is projected to reach USD 3.6 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 4.7% during the forecast period. The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instrumen......
  • Global and Japan PCR Hoods Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 142
    PCR Hoods market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global PCR Hoods market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the PCR Hoods market size by players, by ......
  • Global and United States Medical Shower Beds Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 144
    Medical Shower Beds market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Shower Beds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Medical S......
  • Global and Japan Orthopaedic Robotic System Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 135
    Orthopaedic Robotic System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Orthopaedic Robotic System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Ort......
  • Global and China Cardiotoxicity Screening Market Size, Status and Forecast 2021-2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 108
    Global Cardiotoxicity Screening Scope and Market Size Cardiotoxicity Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiotoxicity Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segm......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs